Zusammenfassung
Im ICD 10 wird in
-
depressive Episoden (F 32.0–32.3) und
-
rezidivierende depressive Störungen (F 33.0–F 33.3) unterteilt.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Ausgewählte Literatur
Ambrosini PJ (2000) A review of pharmacotherapy of major depression in children and adolescents. Psychiat Sery 51: 627–633
Braconnier A, Coent RL, Cohen D (2003) Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind randomized, multicenter trial. J Am Child Adol Psychiatry 42: 22–29
Edwarts JG, Anderson I (1999) Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 57: 507–533
Findling RL, Reed MD, Blumer JL (1999) Pharmacological treatment of depression in children and adolescents. Paed Drugs 1: 161–182
Fleischhaker Ch, Herpertz-Dahlmann B, Holtkamp K, MehlerWex, Warnke A, Schulz E, Wehmeier PM, Remschmidt H (2003) Indikationsspektrum und Nebenwirkungen von „neuen“ Antidepressiva im Rahmen eines multizentrischen Arzneimittelmonitorings — eine Pilotstudie. In: Lehmkuhl U (Hrsg) Psychotherapie und Psychopharmakotherapie im Kindes- und Jugendalter. Vandenhoeck & Ruprecht, Göttingen, 163–167
Harrington R, Whittackerl J, Shoebridge P (1998) Psychological treatment of depression in children and adolescents — a review of treatment research. Br J Psychiatry 173: 291298
Heiser P, Remschmidt H (2002) Die selektiven SerotoninWiederaufnahmehemmer und die neueren Antidepressiva in der Kinder- und Jugendpsychiatrie. Z KinderJugendpsychiatr 30: 173–183
Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, McCafferty JP (2001) Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Child Adol Psychiatry 40: 762–772
Laux G (2003) Depressive Episode and rezidivierende depressive Störung. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie and Psychotherapie. Springer, Berlin
Mandoki MW, Tapia MR, Tapia MA, Sumner GS, Parker JL (1997) Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull 33: 149–154
Wagner KD, Ambrosini PJ (2001) Childhood depression: Pharmacological therapy/treatment. J Clin Child Psychol 30: 88–97
Weller TE, Weller RA, Davis GP (2000) Use of Venlafaxine in children and adolescents: a review of current literature. Depress Anxiety [Suppl 1] 12: 85–89
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Wien
About this chapter
Cite this chapter
Wewetzer, C. (2004). Depression. In: Gerlach, M., Warnke, A., Wewetzer, C. (eds) Neuro-Psychopharmaka im Kindes- und Jugendalter. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3791-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3791-8_15
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-3792-5
Online ISBN: 978-3-7091-3791-8
eBook Packages: Springer Book Archive